DSIP, commonly known as Delta Sleep-Inducing Peptide and also referred to as emideltide, is a synthetic nonapeptide identified by the amino-acid sequence WAGGDASGE.
The compound is documented in chemical reference databases under CAS 62568-57-4 and is supplied here as a research material for qualified laboratory and scientific applications.
Product Classification
Primary Category: Research Peptides
Scientific Category: Synthetic Nonapeptide
Secondary Category: Peptide Research Compounds
Product Type: Research Peptide
Catalog Tags
DSIP · Emideltide · Delta Sleep-Inducing Peptide · Synthetic Nonapeptide · Research Peptide · Laboratory Research · Research Material
Chemical Information
Compound: DSIP
Preferred Substance Name: Emideltide
Common Name: Delta Sleep-Inducing Peptide
Peptide Sequence: WAGGDASGE
CAS Number: 62568-57-4
Molecular Formula: C₃₅H₄₈N₁₀O₁₅
Molecular Weight: Approximately 848.8 g/mol
PubChem CID: 68816
Research Information
DSIP/emideltide is a defined nine-amino-acid peptide that has been investigated in scientific research involving peptide biology and neurobiological systems.
The compound is represented in FDA’s Substance Registration System under the preferred substance name EMIDELTIDE, with DSIP and Delta Sleep-Inducing Peptide listed as synonyms. FDA’s registry also makes clear that a substance’s UNII listing does not mean that the substance has undergone FDA regulatory review or approval.
FDA’s 2026 Pharmacy Compounding Advisory Committee materials evaluated emideltide (free base) and emideltide acetate as separate bulk drug substances. FDA states that neither is a component of an FDA-approved drug.
FDA has also identified potential concerns for compounded products containing emideltide, including possible immunogenicity for certain routes of administration and complexities involving peptide-related impurities and API characterization.
Accordingly, this listing is intentionally limited to compound identity, chemical characteristics, and research classification. It does not represent DSIP as a sleep treatment, medication, or therapeutic product.
Research Applications
DSIP may be examined as a research material in controlled laboratory environments for purposes such as:
Peptide characterization
Analytical testing
Structural investigation
Molecular research
Comparative peptide studies
Laboratory assay development
Neurobiological research
Peptide-related experimental research
These statements describe potential research contexts only and do not constitute recommendations for administration to humans or animals.
Product Specifications
Product Name: DSIP
Preferred Substance Name: Emideltide
Alternative Name: Delta Sleep-Inducing Peptide
Product Type: Synthetic research peptide
Primary Category: Research Peptides
Scientific Classification: Synthetic Nonapeptide
Sequence: WAGGDASGE
CAS: 62568-57-4
Molecular Formula: C₃₅H₄₈N₁₀O₁₅
Molecular Weight: ~848.8 g/mol
Intended Application: Laboratory and scientific research
Important Product Information
Chemical form must be verified before publishing the product specifications.
FDA distinguishes emideltide free base from emideltide acetate as separate bulk drug substances. PubChem likewise identifies DSIP acetate separately, with a molecular weight of approximately 908.9 g/mol.
Therefore, the specifications above should only be used when your actual material corresponds to DSIP/emideltide free base. If your supplier’s COA identifies the product as DSIP acetate, the product page should use the acetate-specific chemical information instead.
Product identity, peptide sequence, purity, salt form, analytical results, and other batch-specific specifications should be verified against the applicable Certificate of Analysis (COA).
Research Use Notice
This product is supplied solely as a research material for qualified laboratory and scientific use.
It is not intended for human consumption, human therapeutic use, veterinary use, diagnosis, treatment, mitigation, or prevention of disease.
Nothing on this product page should be interpreted as a recommendation or representation that DSIP/emideltide is intended to affect the structure or function of the human body.
Not for use as a drug, dietary supplement, food, cosmetic, or medical treatment.
For laboratory research purposes only.




